X-CORTherapeutics is an American developer of a new type of extracorporeal carbon dioxide scavenging device, which is dedicated to developing a carbon dioxide scavenging device for treating acute respiratory failure with ultra-low blood flow. Its new technology is a patent-pending medical device and an accompanying control algorithm, which enables doctors to directly remove excess carbon dioxide from patients with lung failure.
More peer analysis, the company knows and understands.